Sundus Kaimari

Oct 14, 2024 | elifesciences.org | Archana Kamalakar |Brendan Tobin |Sundus Kaimari |M Robinson

eLife assessment Therapeutic treatments for congenital and acquired craniofacial (CF) bone abnormalities are not well developed. This study provides convincing evidence for an innovative regenerative treatment for pediatric craniofacial bone loss using Jagged1-PEG-MAL hydrogel with pediatric human bone cells. The report is a valuable advance in this field.

Oct 10, 2023 | biorxiv.org | Brendan Tobin |Afra Toma |Archana Kamalakar |Sundus Kaimari

AbstractTreatments for congenital and acquired craniofacial (CF) bone abnormalities are limited and expensive. Current reconstructive methods include surgical correction of injuries, short-term bone stabilization, and long-term use of bone grafting solutions, including implantation of (i) allografts which are prone to implant failure or infection, (ii) autografts which are limited in supply.